Company
Stryker
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
431
510(k), De Novo and PMA
Device trials
132
As lead sponsor, any status
Adverse event reports
8,781
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2,406
One per recalled product
Stryker is on our public-company list (ticker SYK). Names searched as well: Howmedica Osteonics. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
SYK
NYSE · STRYKER CORP
Public float
$144.3B
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$25.1B
Fiscal year ending Dec 31, 2025
Net income
$3.25B
Fiscal year ending Dec 31, 2025
R&D spending
$1.62B
Fiscal year ending Dec 31, 2025
Cash
$3.27B
As of Sep 30, 2026
Long-term debt
$14.2B
As of Sep 30, 2026
Shares outstanding
380.7M
As of Sep 30, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | – | $2.98B | – |
| 2024 | – | – | $3.01B | – |
| 2023 | – | – | $1.24B | – |
| 2022 | – | – | $1.50B | – |
| 2021 | – | – | $5.0M | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 431 since 2015.
K262500 · Decided Nov 4, 2026 · 107 days after receipt
Device type: Gown, Non-Sterile, Non-Isolation, Intended To Provide Moderate Or High Barrier Protection (QPC) · General & Plastic Surgery
K262386 · Decided Oct 20, 2026 · 99 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
428 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Citadel Embolization Device StudyCompleted
NCT04057352 · 150 participants · Start Jul 18, 2019 · Primary completion Oct 26, 2026
Device: Citadel Embolization Device · For: Unruptured Wide-neck Aneurysms
Sites: Los Angeles, California; San Francisco, California; Walnut Creek, California · 25 sites in all
NCT03072927 · 8,000 participants (planned) · Start Mar 10, 2017 · Primary completion Dec 2026
Device: MILD; Interspinous Process Decompression · For: Lumbar Spinal Stenosis
Sites: Athens, Alabama; Bay Minette, Alabama; Birmingham, Alabama · 2,450 sites in all
- Triathlon Tritanium Cone Augments Outcomes StudyActive, not recruiting
NCT02521103 · 254 participants · Start Aug 2015 · Primary completion Mar 31, 2025
Device: Triathlon Tritanium Cone Augments · For: Arthroplasty; Replacement; Knee
Sites: Zephyrhills, Florida; Chicago, Illinois; Lexington, Kentucky · 9 sites in all
129 more trials with a free account
Reports received
8,781
Received Nov 1, 2025 to Nov 20, 2026. Includes 21 of another or unstated type.
Malfunction reports
5,709
65% of reports
Injury reports
3,021
34% of reports
Death reports
30
0.3% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 343 | 204 | 1 | 0 |
| Jan 24 | 855 | 291 | 1 | 0 |
| Feb 24 | 316 | 257 | 2 | 0 |
| Mar 24 | 368 | 296 | 6 | 0 |
| Apr 24 | 918 | 307 | 2 | 0 |
| May 24 | 340 | 315 | 1 | 0 |
| Jun 24 | 316 | 211 | 1 | 0 |
| Jul 24 | 937 | 554 | 4 | 0 |
| Aug 24 | 364 | 308 | 3 | 0 |
| Sep 24 | 324 | 361 | 3 | 0 |
| Oct 24 | 1,224 | 341 | 2 | 2 |
| Nov 24 | 324 | 281 | 0 | 1 |
| Dec 24 | 382 | 236 | 1 | 3 |
| Jan 25 | 930 | 396 | 0 | 0 |
| Feb 25 | 301 | 250 | 5 | 0 |
| Mar 25 | 380 | 240 | 0 | 0 |
| Apr 25 | 1,092 | 462 | 1 | 1 |
| May 25 | 346 | 223 | 2 | 0 |
| Jun 25 | 374 | 193 | 5 | 0 |
| Jul 25 | 880 | 408 | 1 | 0 |
| Aug 25 | 343 | 253 | 0 | 0 |
| Sep 25 | 274 | 349 | 0 | 0 |
| Oct 25 | 849 | 592 | 5 | 0 |
| Nov 25 | 310 | 247 | 2 | 0 |
| Dec 25 | 335 | 327 | 1 | 3 |
| Jan 26 | 574 | 185 | 1 | 1 |
| Feb 26 | 320 | 220 | 9 | 0 |
| Mar 26 | 370 | 355 | 4 | 0 |
| Apr 26 | 617 | 199 | 1 | 0 |
| May 26 | 397 | 261 | 4 | 0 |
| Jun 26 | 226 | 151 | 0 | 2 |
| Jul 26 | 593 | 244 | 2 | 3 |
| Aug 26 | 628 | 430 | 0 | 12 |
| Sep 26 | 626 | 217 | 4 | 0 |
| Oct 26 | 713 | 185 | 2 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- NA155
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Precision Pointer Electromagnetic (8000-050-001)Open, Classified
Z-0314-2027 · Started Sep 24, 2026 · Posted by FDA Oct 29, 2026
Reason given: Device may fracture during use at the laser welded joint on the pointer tube. If this happens, loose parts may fall out of the product while the device is inside the patient.
Cause as FDA categorized it: Process control · Device type: Neurological Stereotaxic Instrument (HAW)
Z-0164-2027 · Started Sep 16, 2026 · Posted by FDA Oct 15, 2026
Reason given: Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is used, the 30-minute dry time may lead to a small amount of residual moisture remaining after sterilization.
Cause as FDA categorized it: Labeling design · Device type: Tray, Surgical, Instrument (FSM)
- TS Femoral Prep Tray, Triathlon. Catalog Number: 6543-6-507.Open, Classified
Z-0165-2027 · Started Sep 16, 2026 · Posted by FDA Oct 15, 2026
Reason given: Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is used, the 30-minute dry time may lead to a small amount of residual moisture remaining after sterilization.
Cause as FDA categorized it: Labeling design · Device type: Tray, Surgical, Instrument (FSM)
2,403 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.